This study is in progress, not accepting new patients
Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
Summary
- Eligibility
- for people ages 16 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jesse L. Clark, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Jesse L. Clark, MD
Professor-in-Residence, Medicine. Authored (or co-authored) 48 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- Links
- Gilead Clinical Trials Website Sign up for this study
- ID
- NCT04925752
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 3295 people participating
- Last Updated